206 related articles for article (PubMed ID: 32516488)
21. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.
Jackson SH; Yu CR; Mahdi RM; Ebong S; Egwuagu CE
J Immunol; 2004 Feb; 172(4):2307-15. PubMed ID: 14764699
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
[TBL] [Abstract][Full Text] [Related]
23. The role of suppressor of cytokine signaling 1 as a negative regulator for aberrant expansion of CD8alpha+ dendritic cell subset.
Tsukada J; Ozaki A; Hanada T; Chinen T; Abe R; Yoshimura A; Kubo M
Int Immunol; 2005 Sep; 17(9):1167-78. PubMed ID: 16091384
[TBL] [Abstract][Full Text] [Related]
24. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
25. Lysyl-Transfer RNA Synthetase Induces the Maturation of Dendritic Cells through MAPK and NF-κB Pathways, Strongly Contributing to Enhanced Th1 Cell Responses.
Lim HX; Jung HJ; Lee A; Park SH; Han BW; Cho D; Kim TS
J Immunol; 2018 Nov; 201(9):2832-2841. PubMed ID: 30275047
[TBL] [Abstract][Full Text] [Related]
26. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of SOCS1-silenced dendritic cells in vitro.
Jiang Q; Wang X; Qian M; Chen D; Xu Y
Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
[TBL] [Abstract][Full Text] [Related]
27. Triggering of NF-κB in cytokine-matured human DCs generates superior DCs for T-cell priming in cancer immunotherapy.
Pfeiffer IA; Hoyer S; Gerer KF; Voll RE; Knippertz I; Gückel E; Schuler G; Schaft N; Dörrie J
Eur J Immunol; 2014 Nov; 44(11):3413-28. PubMed ID: 25100611
[TBL] [Abstract][Full Text] [Related]
28. Per a 10 protease activity modulates CD40 expression on dendritic cell surface by nuclear factor-kappaB pathway.
Goel C; Kalra N; Dwarakanath BS; Gaur SN; Arora N
Clin Exp Immunol; 2015 May; 180(2):341-51. PubMed ID: 25492061
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of dendritic cell maturation by the tumor microenvironment correlates with the survival of colorectal cancer patients following bevacizumab treatment.
Michielsen AJ; Noonan S; Martin P; Tosetto M; Marry J; Biniecka M; Maguire AA; Hyland JM; Sheahan KD; O'Donoghue DP; Mulcahy HE; Fennelly D; Ryan EJ; O'Sullivan JN
Mol Cancer Ther; 2012 Aug; 11(8):1829-37. PubMed ID: 22675042
[TBL] [Abstract][Full Text] [Related]
30. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation.
Morrissey ME; Byrne R; Nulty C; McCabe NH; Lynam-Lennon N; Butler CT; Kennedy S; O'Toole D; Larkin J; McCormick P; Mehigan B; Cathcart MC; Lysaght J; Reynolds JV; Ryan EJ; Dunne MR; O'Sullivan J
BMC Cancer; 2020 Jun; 20(1):566. PubMed ID: 32552799
[TBL] [Abstract][Full Text] [Related]
31. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
32. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
33. Mycobacterium tuberculosis PE27 activates dendritic cells and contributes to Th1-polarized memory immune responses during in vivo infection.
Kim WS; Kim JS; Cha SB; Kim SJ; Kim H; Kwon KW; Han SJ; Choi SY; Shin SJ
Immunobiology; 2016 Mar; 221(3):440-53. PubMed ID: 26655143
[TBL] [Abstract][Full Text] [Related]
34. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
Zhu M; Xu W; Su H; Huang Q; Wang B
Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells that highly express SOCS1 induce T-cell hypo-responsiveness and prolong islet allograft survival.
Lu X; Chen M; Xue Z; Zhang X; Xu J; Wu L; Deng R; Ma Y
Cell Immunol; 2017 Apr; 314():36-41. PubMed ID: 28215626
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus surface antigen can activate human monocyte-derived dendritic cells by nuclear factor kappa B and p38 mitogen-activated protein kinase mediated signaling.
Jan RH; Lin YL; Chen CJ; Lin TY; Hsu YC; Chen LK; Chiang BL
Microbiol Immunol; 2012 Oct; 56(10):719-27. PubMed ID: 22853328
[TBL] [Abstract][Full Text] [Related]
37. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways.
Alam MM; Yang D; Trivett A; Meyer TJ; Oppenheim JJ
Front Immunol; 2018; 9():2982. PubMed ID: 30619338
[TBL] [Abstract][Full Text] [Related]
38. Dominance of CD86, transforming growth factor- beta 1, and interleukin-10 in Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulates T helper 1 responses to mycobacterial antigens.
Balkhi MY; Sinha A; Natarajan K
J Infect Dis; 2004 May; 189(9):1598-609. PubMed ID: 15116295
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells.
Lyakh LA; Sanford M; Chekol S; Young HA; Roberts AB
J Immunol; 2005 Feb; 174(4):2061-70. PubMed ID: 15699136
[TBL] [Abstract][Full Text] [Related]
40. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
